Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

Autor: Lopez-Pousa, A, Rifa, J, De Tejerina, AC, Gonzalez-Larriba, JL, Iglesias, C, Gasquet, JA, Carrato, A

Publikováno v: EUROPEAN JOURNAL OF CANCER CARE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Chemotherapy-induced neutropenia, the major dose-limiting toxicity of chemotherapy, is directly associated with concomitant morbidity, mortality and health-care costs. The use of prophylactic granulocyte colony-stimulating factors may reduce the inci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::edc67c404da3d87a9df3de11413d16e7
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12594